Rathbones Group PLC Edwards Lifesciences Corp Transaction History

Rathbones Group PLC

$19.7 Billion
Q1 2025

A detailed history of Rathbones Group PLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rathbones Group PLC holds 628,075 shares of EW stock, worth $47.6 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

628,075

Previous 1,299,171 51.66%

Holding current value

$47.6 Million

Previous $96.2 Million 52.67%

% of portfolio

0.23%

Previous 0.49%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$67.95 - $76.19 $45.6 Million - $51.1 Million	-671,096 Reduced 51.66%	628,075 $45.5 Million
Q4 2024 Feb 13, 2025	BUY	$64.54 - $75.92 $980,491 - $1.15 Million	15,192 Added 1.18%	1,299,171 $96.2 Million
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $21.7 Million - $34 Million	363,051 Added 39.42%	1,283,979 $84.7 Million
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $2.73 Million - $3.06 Million	32,422 Added 3.65%	920,928 $85.1 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $5.48 Million - $7.22 Million	75,529 Added 9.29%	888,506 $84.9 Million
Q4 2023 Feb 13, 2024	BUY	$61.71 - $77.76 $5.56 Million - $7 Million	90,025 Added 12.45%	812,977 $62 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $10.1 Million - $13.5 Million	145,089 Added 25.11%	722,952 $50.1 Million
Q2 2023 Aug 04, 2023	BUY	$81.41 - $94.33 $3 Million - $3.48 Million	36,865 Added 6.81%	577,863 $54.5 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $3.6 Million - $4.1 Million	48,481 Added 9.84%	540,998 $44.8 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $3.6 Million - $4.61 Million	52,724 Added 11.99%	492,517 $36.7 Million
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $734,658 - $956,919	8,919 Added 2.07%	439,793 $36.3 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $2.48 Million - $3.67 Million	28,635 Added 7.12%	430,874 $41 Million
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $1.03 Million - $1.3 Million	10,101 Added 2.58%	402,239 $47.4 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $2.77 Million - $3.4 Million	26,049 Added 7.12%	392,138 $50.8 Million
Q3 2021 Nov 04, 2021	BUY	$102.91 - $122.75 $5,042 - $6,014	49 Added 0.01%	366,089 $41.4 Million
Q2 2021 Jul 30, 2021	BUY	$83.84 - $104.76 $4.14 Million - $5.18 Million	49,435 Added 15.61%	366,040 $37.9 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $6.48 Million - $7.46 Million	82,311 Added 35.13%	316,605 $26.5 Million
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $8.74 Million - $11.1 Million	121,929 Added 108.51%	234,294 $21.4 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $5.78 Million - $7.52 Million	86,020 Added 326.51%	112,365 $8.97 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $1.43 Million - $1.91 Million	24,838 Added 1648.18%	26,345 $1.82 Million
Q1 2020 May 04, 2020	BUY	$52.41 - $81.0 $78,981 - $122,067	1,507 New	1,507 $284,000

Others Institutions Holding EW

# of Institutions

1,377

Shares Held

486M

Call Options Held

2.77M

Put Options Held

2.05M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Edwards Lifesciences Corp Transaction History